Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bispectral Index and Patient State Index During General Anesthesia With Remimazolam: a Prospective Observational Study

NCT05432050 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT05432050
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05432050 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bispectral Index and Patient State Index During General Anesthesia With Remimazolam: a Prospective Observational Study
Lead sponsor
Seoul National University Hospital
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2022
Completion date
December 31, 2023
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia, general, breast diseases, hypnotics and sedatives, parathyroid diseases, remimazolam, thyroid disease